Document is current
Any future updates will be listed below
-
Authors
Lakhal, Karim https://orcid.org/0000-0002-5311-3987
Lasocki, Sigismond
- License Information
-
More Information
Article History
Received: 8 August 2025
Accepted: 29 August 2025
First Online: 8 October 2025
Declarations
:
: K.L. has no conflict of interest in connection with the work submitted. In addition, K.L. declares having received consulting fees from Philips since 2024. Over the past three years, K.L. has also received congress registration support from Pfizer (once in 2022) as well as congress registration and travel fees from Advanz Pharma/Correvio (once in 2024) and AOP Health (once in 2024). S.L. is the principal investigator of the MiVAR study (ClinicalTrials.gov identifier NCT04362527). S.L. has no other conflicts of interest to declare in connection with the submitted work.
